Peguis Pharmacies Receive Shipment of COVID-19 Vaccines

March 12, 2021Blog Posts

We are pleased to announce that all our pharmacy locations have received doses of COVID-19 vaccines. However; due to the short supply, individuals must meet the criteria to be eligible must phone their local Peguis Pharmacy to make an appointment.

The (standard) COVID-19 Immunization Consent Form MUST be completed prior to completing this Enhanced Consent Form. Individuals who are pregnant, planning to become pregnant or breastfeeding; immunosuppressed due to disease or treatment and/or have an autoimmune condition are to complete two consent forms.

Eligibility Criteria

As part of the piloted roll-out of the AstraZeneca/Covishield, Manitobans aged 50 to 64 years (First Nations people aged 30 to 64) with a high-risk condition will be the first group eligible to receive the AstraZeneca/Covishield COVID-19 vaccine. These individuals are at increased risk of experiencing serious illness requiring hospitalization or death related to COVID-19.

Anyone who is ALREADY eligible for the Pfizer/Moderna COVID-19 vaccine (such as health care workers) and is aged 18 to 64 is also eligible to receive AstraZeneca/ Covishield COVID-19 vaccine.

However, anyone who has already received a dose of the Pfizer or Moderna mRNA vaccines must use the same product for their second dose, and should not receive the AstraZeneca/Covishield vaccine.

People with high-risk conditions (as determined by their doctor or pharmacist) will be prioritized, with those who have a condition in Priority List 1 being offered immunization before those with a condition in Priority List 2.

Priority List 1:

• Individuals with the following chronic health conditions:
  • end stage renal disease undergoing hemodialysis OR peritoneal dialysis
  • cirrhosis due to any cause OR portal hypertension
  • heart failure (class III/IV ), ventricular assist device OR adult congenital heart disease stage C and D
  • severe COPD, pulmonary hypertension, pulmonary fibrosis, interstitial lung disease OR cystic fibrosis
  • history of cerebral vascular accident with residual deficits
  • malignant hematologic disorders including leukemia and lymphoma OR clonal blood disorder
  • malignant neoplasms (solid tissue) who will receive or are currently receiving immunosuppressive therapy including chemotherapy
  • severe obesity (BMI ≥ 40)
  • receiving one or more of the following immunosuppressive therapies: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors, chronic dose prednisone >=20mg/day, mycophenolate, sulfasalazine and JAK inhibitors (e.g., tofacitinib)
  • solid organ or hematopoietic stem cell transplant (candidate or recipient)
  • trisomy 21 (Down syndrome)
  • asplenia or hyposplenism (including sickle cell disease)
• Individuals receiving home care ≥ 4 times/week OR receive 24/7 support from Community Living Disability Services.
• Pregnant individuals (18 to ≤ 64 years of age) with one of: aged ≥ 35 years, BMI ≥ 30, pre-existing diabetes, pre-existing hypertension, cardiac or pulmonary disease.

Priority List 2:

• Individuals with the following chronic health conditions:
  • Chronic cardiovascular disease including heart failure (class I/II), coronary artery disease, malignant tachyarrythmia OR cardiomyopathies
  • chronic liver disease
  • chronic neurologic OR neurodevelopmental conditions including cerebral palsy, Parkinson’s disease, multiple sclerosis, ALS OR dementia (including Alzheimer’s disease)
  • chronic pulmonary disease including COPD OR severe and/or uncontrolled asthma
  • chronic renal disease
  • HIV (CD4 cell count ≥ 200 x 106/L and CD4 percentage ≥ 15%)
  • severe systemic autoimmune disorders (e.g., systemic lupus erythematosus, scleroderma, myocarditis, rheumatoid arthritis)
  • type 1 or 2 diabetes mellitus (poorly controlled and/or with complications)
  • active tuberculosis (current or previous) OR current latent tuberculosis (LTBI)
  • receiving immunosuppressing therapy
• Individuals receiving homecare ≤ 3 times/week OR any level of Community Living Disability Services supports (or as per family physician determination of equivalent levels of family support).
• Household contacts of individuals with Priority 1 chronic health conditions OR designated support person(s) for personal care home residents 

LOCATIONS

Chief Peguis Pharmacy
Peguis Mall
204 645 5935

Peguis Pharmacy – Selkirk
103-620 Manitoba Ave
204 482 8353

Peguis Pharmacy – Winnipeg
102-1065 Portage Ave
204 774 0043